Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 6/20 | 0.57 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.54 |
| ▸ | CASP2 | P42575 | 1/20 | 0.53 |
| ▸ | SELP | P16109 | 1/20 | 0.51 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.50 |
| ▸ | NAAA | Q02083 | 1/20 | 0.50 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.47 |
| ▸ | CNR1 | P21554 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10413909 | 0.90 | CASP2 (0.59) | FAAHDNM1CASP2SELPEPHX2 | |
| SCHEMBL23802554 | 0.90 | CASP2 (0.59) | FAAHDNM1CASP2SELPEPHX2 | |
| SCHEMBL9714311 | 0.89 | FAAH (0.54) | FAAHDNM1CASP2SELPEPHX2 | |
| SCHEMBL17274366 | 0.85 | FAAH (0.56) | FAAHDNM1CASP2SELPEPHX2 | |
| SCHEMBL227920 | 0.80 | FAAH (0.77) | FAAHDNM1CASP2SELPEPHX2 | |
| SCHEMBL25350370 | 0.80 | FAAH (0.77) | FAAHDNM1CASP2SELPEPHX2 | |
| SCHEMBL11170358 | 0.80 | FAAH (0.77) | FAAHDNM1CASP2SELPEPHX2 | |
| SCHEMBL8461970 | 0.80 | FAAH (0.77) | FAAHDNM1CASP2SELPEPHX2 | |
| SCHEMBL846255 | 0.80 | FAAH (0.77) | FAAHDNM1CASP2SELPEPHX2 | |
| SCHEMBL14576744 | 0.80 | FAAH (0.77) | FAAHDNM1CASP2SELPEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2516473-B1 | ANIONIC POLYSACCHARIDES FUNCTIONALISED WITH A DERIVATIVE OF HYDROPHOBIC ACID | ADOCIA (FR) | 2020-09-30 | — | — | EP | disclosed |
| US-9493583-B2 | Anionic polysaccharides functionalized by a hydrophobic acid derivative | ADOCIA (FR) | 2016-11-15 | — | — | US | disclosed |
| EP-2516473-A1 | ANIONIC POLYSACCHARIDES FUNCTIONALISED BY A HYDROPHOBIC ACID DERIVATIVE | Adocia (FR) | 2012-10-31 | — | — | EP | disclosed |
| US-20110172166-A1 | Anionic polysaccharides functionalized by a hydrophobic acid derivative | ADOCIA (FR) | 2011-07-14 | — | — | US | disclosed |
| WO-2011077405-A1 | ANIONIC POLYSACCHARIDES FUNCTIONALISED BY A HYDROPHOBIC ACID DERIVATIVE | ADOCIA (FR) | 2011-06-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110172166-A1 | Anionic polysaccharides functionalized by a hydrophobic acid derivative | ALG1, CD44, FUT6 | FAAH 3193/4885DNM1 4329/4885CASP2 3094/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.